Literature DB >> 17625088

Stem cells for lung disease.

Michael R Loebinger1, Sam M Janes.   

Abstract

Respiratory diseases remain one of the main causes of morbidity and mortality in the world. Interest has increased as to the possibility of optimizing the repair of the lung with the manipulation of stem cells. Embryonic and adult stem cells have been suggested as possibilities. Adult stem cells have traditionally been thought of as having limited differentiation ability and to be organ specific. However, a series of exciting reports over the last 5 to 10 years have suggested that adult bone marrow-derived stem cells may have more plasticity and are able to differentiate into bronchial and alveolar epithelium, vascular endothelium, and interstitial cell types, making them prime candidates for repair. This article critically reviews the evidence for this plasticity and the use of predominantly adult stem cells to help with lung regeneration and repair and assesses how this technology may be utilized in clinical medicine.

Entities:  

Mesh:

Year:  2007        PMID: 17625088     DOI: 10.1378/chest.06-2751

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  13 in total

Review 1.  Knowledge translation: airway epithelial cell migration and respiratory diseases.

Authors:  Helan Xiao; Debbie X Li; Mingyao Liu
Journal:  Cell Mol Life Sci       Date:  2012-06-21       Impact factor: 9.261

Review 2.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Jay K Kolls; Luis A Ortiz; Angela Panoskaltsis-Mortari; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2008-07-15

3.  Stem cells and cell therapies in lung biology and lung diseases.

Authors:  Daniel J Weiss; Ivan Bertoncello; Zea Borok; Carla Kim; Angela Panoskaltsis-Mortari; Susan Reynolds; Mauricio Rojas; Barry Stripp; David Warburton; Darwin J Prockop
Journal:  Proc Am Thorac Soc       Date:  2011-06

4.  Cell therapy with bone marrow mononuclear cells in elastase-induced pulmonary emphysema.

Authors:  Nathalia Longhini-Dos-Santos; Valter Abraão Barbosa-de-Oliveira; Rodrigo Heras Kozma; Carolina Arruda de Faria; Talita Stessuk; Fernando Frei; João Tadeu Ribeiro-Paes
Journal:  Stem Cell Rev Rep       Date:  2013-04       Impact factor: 5.739

5.  Circulating CD34(+) cells are elevated in neonates with respiratory distress syndrome.

Authors:  Yuanyuan Qi; Liling Qian; Bo Sun; Chao Chen; Yun Cao
Journal:  Inflamm Res       Date:  2010-04-30       Impact factor: 4.575

Review 6.  Mesenchymal stem cells as vectors for lung disease.

Authors:  Michael R Loebinger; Elizabeth K Sage; Sam M Janes
Journal:  Proc Am Thorac Soc       Date:  2008-08-15

7.  Diagnosis and management of miliary tuberculosis: current state and future perspectives.

Authors:  Sayantan Ray; Arunansu Talukdar; Supratip Kundu; Dibbendhu Khanra; Nikhil Sonthalia
Journal:  Ther Clin Risk Manag       Date:  2013-01-08       Impact factor: 2.423

8.  Intratracheal administration of umbilical cord blood-derived mesenchymal stem cells in a patient with acute respiratory distress syndrome.

Authors:  Youjin Chang; So Hee Park; Jin-Won Huh; Chae-Man Lim; Younsuck Koh; Sang-Bum Hong
Journal:  J Korean Med Sci       Date:  2014-02-27       Impact factor: 2.153

Review 9.  Clinical potentials of human pluripotent stem cells in lung diseases.

Authors:  Yuan Quan; Dachun Wang
Journal:  Clin Transl Med       Date:  2014-06-17

10.  Intravenous and intratracheal mesenchymal stromal cell injection in a mouse model of pulmonary emphysema.

Authors:  Jeroen Tibboel; Richard Keijzer; Irwin Reiss; Johan C de Jongste; Martin Post
Journal:  COPD       Date:  2013-12-02       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.